Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVidendum Plc Regulatory News (VID)

Share Price Information for Videndum Plc (VID)

Share Price is delayed by 15 minutes
Get Live Data
377.50    -14.50 (-3.70%)
Bid:
375.00
Ask:
380.00
Spread: 5.00 (1.333%)
Market Cap: £157.95m
VID Live PriceLast checked at - London Stock Exchange

Intraday Videndum Plc Share Chart

Update Announcement

23 Dec 2025 07:00

RNS Number : 5659M
Videndum PLC
23 December 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO THE SAME WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

FOR IMMEDIATE RELEASE

 

23 December 2025

 

Videndum plc

 

Update announcement

 

Videndum plc (the "Company" or the "Group") is pleased to provide an update on its ongoing negotiations with its revolving credit facility ("RCF") lenders and its two largest shareholders.

 

Proposed Refinancing

 

The Company continues to make constructive progress with its RCF lenders and its two largest shareholders on a deleveraging plan. As outlined in the Company's 30 April 2025, 6 August 2025 and 16 October 2025 announcements, any plan to deleverage the business will require alternative new sources of liquidity including, but not limited to, any combination of proceeds from disposals, new debt facilities and the raising of new debt or equity.

 

The Group's net debt as at 30 November 2025 was £143.3 million, including £26.5 million of finance leases. 

 

All matters remain under consideration and subject to agreeing final, legally binding documentation, but the main components of a refinancing proposal (the "Refinancing") have now been agreed in-principle with the RCF lenders and the Company's two largest shareholders. The Refinancing comprises:

 

· a Firm Placing, Placing and Open Offer to raise c.£70 million (gross). The two largest institutional shareholders of the Company have indicated their in-principle support to participate in this equity raise, at least pro rata on a post-Refinancing basis;

· the equitisation of c.£23 million of RCF debt in exchange for new equity for Polus Capital, a private credit lender which has been one of the RCF lenders for some time;

· the repayment of c.£50 million of the Group's existing RCF from the proceeds of the equity raise; and

· the restructuring of the remainder of the Group's existing RCF, including to provide the Group with sufficient maturity (three years £31.5 million tranche A; two year £13.5 million tranche B) and acceptable coupon and covenants, alongside the entry into a new three year Super Senior Facility underwritten by Polus Capital.

 

As a result of the Refinancing, the Group's pro forma net debt as at 30 November 2025 would have been c.£52 million, including £26.5 million of finance leases, representing a reduction in net debt of more than £90 million. Following the completion of the proposed Refinancing, the Company will have significantly deleveraged its capital structure, materially improved its key credit metrics and well positioned to deliver on its business potential with the support of the new Super Senior Facility and available cash on balance sheet.

 

The components noted above are inter-conditional, and the Refinancing remains subject to the finalisation of terms, credit and/or investment committee approvals and agreement of long-form documentation. Accordingly, there can be no certainty that the Refinancing will be carried out, nor as to its terms, if completed.

 

The issuance of new shares will require shareholder approvals at a general meeting. These are expected to include approval for the Company to issue new shares very significantly below their current nominal value of 20 pence per share. The Company currently expects the Refinancing to complete by the end of Q1 2026.

 

While the Refinancing will allow for existing shareholders to participate in the equity raise, the Company expects that the value attributable to existing shareholders in respect of their current shareholdings will be very significantly diluted. If the Refinancing does not successfully complete, it is expected that the lending banks would pursue an alternative lender-led transaction to preserve the ability of the Group (other than the Company) to trade as a going concern. It is likely that such a transaction would result in no recovery for existing shareholders.

 

Stephen Harris, Executive Chairman, said, "Reaching in-principle agreement on the terms of the refinancing is an important milestone for Videndum. The proposed Refinancing will help secure a stable and sustainable future for the business and position Videndum for long-term success. It will be a good outcome for Videndum, and we are grateful for the support we have received from our Shareholders and Lenders to date".

 

Covenants

 

The Company has extended or had waived all relevant covenant tests since its previous update announcement on 16 October 2025.

 

A further announcement will be released as and when appropriate.

 

Enquiries

 

Videndum

Stephen Harris

Group Executive Chairman

Telephone: 020 8332 4602

 

FTI Consulting

Richard Mountain / Ben Fletcher

Telephone: 020 3272 1340

 

A snapshot of Videndum plc

 

Videndum is a leading global provider of premium branded hardware products and software solutions to the content creation market.

 

Videndum's customers include broadcasters, film studios, production and rental companies, photographers, independent content creators ("ICCs"), professional musicians and enterprises. Our product portfolio includes camera supports, video transmission systems and monitors, live streaming solutions, robotic camera systems, prompters, LED lighting, mobile power, carrying solutions, backgrounds, audio capture, and noise reduction equipment.

 

We employ around 1,300 people across the world in 9 different countries. Videndum plc is listed on the London Stock Exchange, ticker: VID.

 

More information can be found at: https://videndum.com/

 

LEI number: 2138007H5DQ4X8YOCF14

 

This announcement contains inside information for the purposes of the market abuse regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended. The person responsible for arranging the release of this announcement on behalf of Videndum is Jon Bolton.

 

This announcement may contain forward-looking statements, which relate, inter alia, to the Company's proposed strategy, plans and objectives. Forward-looking statements are sometimes identified by the use of terminology such as (but not limited to) "believes", "expects", "may", "will", "could", "shall", "risk", "intends", "estimates", "aims", "plans", "predicts", "continues", "assumes", "positions" or "anticipates" or the negatives thereof, other variations thereon or comparable terminology. By its very nature, such forward-looking information requires the Company to make assumptions that may or may not materialise. Although the Directors consider that these assumptions are reasonable, such forward-looking statements may involve known and unknown risks, uncertainties, assumptions and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Group to be materially different from such forward-looking statements. Past performance is not a reliable indicator of future results and, in particular, past performance of the Group cannot be relied upon as a guide to future performance. Forward-looking statements speak only as of the date they are made. Accordingly, you should not rely on any forward-looking statements and the Company, Lazard and Investec expressly disclaim any obligation to disseminate any updates or revisions to such forward-looking statements. No statement in this announcement is intended as a profit forecast or a profit estimate and no statement in this announcement should be interpreted to mean that earnings per share for the current or future financial periods would necessarily match or exceed historical published earnings per share. As a result, you are cautioned not to place any undue reliance on such forward-looking statements. Neither the Company nor anyone else is under any obligation to update or keep current the information contained in this announcement.

 

This announcement is not a prospectus and not an offer of shares or any other securities for sale and investors should not subscribe for or purchase any shares or securities referred to in this announcement except on the basis of the information in any prospectus, including the risk factors set out therein, that may be published by the Company in due course in relation to a potential offer for sale of new ordinary shares in the capital of the Company and admission of those ordinary shares to trading on London Stock Exchange plc's main market for listed securities and to listing in the equity shares (commercial companies) category of the official list of the FCA.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPKBBBNBDBQBB
Date   Source Headline
8th Dec 202311:30 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20231:04 pmRNSResults of Capital Raising and General Meeting
5th Dec 20233:31 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTotal Voting Rights
21st Nov 202312:56 pmRNSPublication of Prospectus
21st Nov 20237:00 amRNSCompletion of Bookbuild
20th Nov 20235:27 pmRNSProposed Capital Raising
20th Nov 20237:00 amRNSBlock listing Interim Review
9th Nov 20237:00 amRNSAppointment of Director & Chairman Designate
8th Nov 20239:56 amRNSGraham Oldroyd change of role
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSDirectorate Change
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
9th Oct 202310:00 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 202312:45 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:35 pmRNSTotal Voting Rights
26th Sep 20237:00 amRNSDirectorate Change
26th Sep 20237:00 amRNSVidendum plc - 2023 Interim Results
25th Sep 20234:37 pmRNSRevised publication date of 2023 Interim Results
14th Sep 202312:00 pmRNSBlocklisting Application for Sharesave and LTIP
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20234:47 pmRNSHolding(s) in Company
24th Aug 202310:57 amRNSHolding(s) in Company
9th Aug 20234:33 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSRevision of Half Year Results Date
1st Aug 20237:00 amRNSTotal Voting Rights
27th Jul 202311:30 amRNSNew directorship held in another UK plc
30th Jun 20232:00 pmRNSTotal Voting Rights
19th Jun 20235:11 pmRNSHolding(s) in Company
1st Jun 20238:47 amRNSTotal Voting Rights
19th May 20238:00 amRNSBlock listing Interim Review
11th May 20231:09 pmRNSResult of 2023 Annual General Meeting
9th May 202310:45 amRNSDirector/PDMR Shareholding
2nd May 20233:14 pmRNSUpdate Announcement
2nd May 20239:49 amRNSTotal Voting Rights
19th Apr 20235:05 pmRNSHolding(s) in Company
13th Apr 20234:15 pmRNSNew directorship held in another public company
4th Apr 202312:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSAnnual Report & Accounts and Notice of 2023 AGM
10th Mar 20239:24 amRNSHolding(s) in Company
3rd Mar 202311:15 amRNSDirector/PDMR Shareholding
1st Mar 202311:03 amRNSTotal Voting Rights
28th Feb 20237:00 amRNS2022 Full Year Results
1st Feb 20239:00 amRNSTotal Voting Rights
3rd Jan 202310:30 amRNSTotal Voting Rights
14th Dec 20227:00 amRNSBoard changes
5th Dec 202210:16 amRNSHolding(s) in Company
1st Dec 20221:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.